BIOMED PHARMACOTHER 润色咨询

BIOMEDICINE & PHARMACOTHERAPY

出版年份:1982 年文章数:8228 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:10.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2023-10-27 ms5000002099693562 来自湖北省

    最近为什么这么慢啊

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2023-11-02 ms1000000865900030 来自贵州省

    偏重的研究方向:肿瘤;综述
    经验分享:从submit到with editor 花了21天

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2023-11-03 ms8000001306180750 来自广东省

    真的是慢到离谱

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-03-13 ms2000001254072347 来自四川省

    偏重的研究方向:肿瘤;综述
    经验分享:为啥找不到审稿人呢

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-04-10 ms7000000856963905 来自北京

    记录一下:
    2023年12月26号 投稿
    2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)
    2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)
    那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号
    2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收
    2024年4月4号 编辑决定accept
    2024年4月10号 online
    总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-04-06 14724b31m63暂无昵称 来自吉林省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:类风湿关节炎
    经验分享:11-17Submit New Manuscript
    12-7Submissions Sent Back to Author 要求更改WB原始数据格式
    12-13Submit New Manuscript
    1-11With editor
    1-14、1-16 1-17 1-29 Under review
    2-13 Required Reviews completed
    2-14Decision in progress
    2-17Revise
    3-7Revised Manuscript Submitted
    3-7Under Review
    3-15Revise
    3-28 Revision submitted to journal
    3-28Under Review
    4-1Required Reviews Completed
    4-4 Accepted

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-03-29 Zhou zhongsheng 来自吉林

    审稿速度:1.0
    偏重的研究方向:类风湿学研究;inflammation;免疫学研究
    经验分享:基础研究 今天接收了

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-01-31 ms8000001441772842 来自北京

    多久有人愿意审稿呀。

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
    2024-03-08 chy 来自辽宁省

    记录一下,2.16投稿的,1300+,今天还是Submitted to journal

    12

    展开12条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2165305, encodeId=3c7121653050f, content=最近为什么这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b1a8790665, createdName=ms5000002099693562, createdTime=Fri Oct 27 18:04:53 CST 2023, time=2023-10-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2166373, encodeId=9cbe21663e32c, content=偏重的研究方向:肿瘤;综述<br>经验分享:从submit到with editor 花了21天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b42e5711504, createdName=ms1000000865900030, createdTime=Thu Nov 02 22:12:08 CST 2023, time=2023-11-02, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2166470, encodeId=aa4421664e080, content=真的是慢到离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32428409704, createdName=ms8000001306180750, createdTime=Fri Nov 03 12:19:04 CST 2023, time=2023-11-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2197732, encodeId=af9a219e73285, content=记录一下:<br>2023年12月26号 投稿<br>2024年1月31号 under review(送了好几位审稿人,最后2位同意审稿)<br>2024年2月9号 1审意见返回,其中一位要求补实验,另一位回答疑问(要求2月29号前返修)<br>那段时间过年回家加上忙毕业论文,时间来不及,写信申请延长至3月31号<br>2024年3月31号 返修,其中一位审稿人疑似跑路,另一位审稿人建议接收<br>2024年4月4号 编辑决定accept<br>2024年4月10号 online<br>总之,期刊编辑还是很人性化,处理邮件也很及时,一审审稿人问题很有启发,补充实验后确实能提升文章水平,其中一位审稿人跑路也没重新送审(很多期刊遇到这种情况都是再次送审,就挺耽误时间)。<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18898386622, createdName=ms7000000856963905, createdTime=Wed Apr 10 13:17:44 CST 2024, time=2024-04-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197163, encodeId=f265219e16355, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:类风湿关节炎<br>经验分享:11-17Submit New Manuscript <br>12-7Submissions Sent Back to Author 要求更改WB原始数据格式<br>12-13Submit New Manuscript <br>1-11With editor <br>1-14、1-16 1-17 1-29 Under review <br>2-13 Required Reviews completed <br>2-14Decision in progress <br>2-17Revise <br>3-7Revised Manuscript Submitted <br>3-7Under Review<br>3-15Revise <br>3-28 Revision submitted to journal<br>3-28Under Review<br>4-1Required Reviews Completed<br>4-4 Accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=573b5194794, createdName=14724b31m63暂无昵称, createdTime=Sat Apr 06 18:58:09 CST 2024, time=2024-04-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2195970, encodeId=73ac21959e084, content=审稿速度:1.0<br>偏重的研究方向:类风湿学研究;inflammation;免疫学研究<br>经验分享:基础研究 今天接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Fri Mar 29 02:34:14 CST 2024, time=2024-03-29, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=请问Rights & Access form sent to you for completion这个阶段不需要点击什么是嘛?是不是还没有到proof。 接收,proof,支付是三个邮件嘛?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2024-03-28, status=1, ipAttribution=北京)]
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分